PTEN and neoplasm: However, tumor invasion in mice bearing QGP-1 xenografts with PTEN loss was significantly suppressed by MAZ51 treatment (Wilcoxon rank-sum test, P = 0.021) and tended to be suppressed by trametinib treatment (Wilcoxon rank-sum test, P = 0.096).